Prescott Group Capital Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-60,135
Closed -$551K 254
2025
Q1
$551K Sell
60,135
-4
-0% -$25 0.08% 190
2024
Q4
$402K Sell
60,139
-23,334
-28% -$205K 0.05% 221
2024
Q3
$839K Buy
83,473
+31,269
+60% +$456K 0.12% 177
2024
Q2
$814K Sell
52,204
-3,767
-7% -$63.1K 0.13% 179
2024
Q1
$1.23M Buy
+55,971
New +$1.24M 0.2% 139
2023
Q3
Sell
-8,465
Closed -$156K 177
2023
Q2
$156K Hold
8,465
0.03% 157
2023
Q1
$245K Sell
8,465
-202
-2% -$5.38K 0.06% 157
2022
Q4
$240K Buy
+8,667
New +$329K 0.05% 175

Prescott Group Capital Management's OPTN Position: Q2 2025 in Review

Prescott Group Capital Management sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 60,135 shares — an estimated $551K sold.

Prescott Group Capital Management first reported a position in OPTN in Q4 2022 and held it in 8 quarters. The position peaked at $1.23M in Q1 2024. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • Prescott Group Capital Management reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • Prescott Group Capital Management sold 60,135 OptiNose shares in Q2 2025, an estimated $551K.
  • Prescott Group Capital Management first reported a position in OptiNose in Q4 2022 and held it in 8 quarters.
  • Prescott Group Capital Management's OptiNose position peaked at $1.23M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Prescott Group Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.